4//SEC Filing
Insys Therapeutics, Inc. 4
Accession 0001209191-16-136214
CIK 0001516479operating
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 7:12 PM ET
Size
5.1 KB
Accession
0001209191-16-136214
Insider Transaction Report
Form 4
BRENNAN DANIEL
Exec VP & Chf Operations Off.
Transactions
- Sale
Common Stock
2016-08-09$19.16/sh−5,781$110,752→ 1 total
Footnotes (1)
- [F1]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.04 to $19.31 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Insys Therapeutics, Inc.
CIK 0001516479
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001516479
Filing Metadata
- Form type
- 4
- Filed
- Aug 8, 8:00 PM ET
- Accepted
- Aug 9, 7:12 PM ET
- Size
- 5.1 KB